GlassScriptPhysician profile
Sierra C Cuthpert
NPI 1104171297
$1,027.22
in general payments reported to CMS, 2019-2025
12 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $194 · 2021: $105 · 2022: $53.19 · 2023: $12.90 · 2024: $98.28 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $341.78 | 2019-2025 | |
| Coopersurgical, INC. | $167.83 | 2019-2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $136.81 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Biogen, INC. | $90.80 | 2025 | Zurzuvae |
| Intuitive Surgical, INC. | $75.40 | 2022-2025 | |
| Organon LLC | $56.95 | 2025 | Nexplanon |
| Pfizer INC. | $50.44 | 2023-2024 | |
| Daiichi Sankyo INC. | $42.67 | 2019-2020 | |
| Baxter Healthcare | $22.15 | 2020 | |
| Aspira Women'S Health INC | $19.61 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.62 | 2020 | |
| Covidien LP | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sierra Cuthpert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.